Results for 'biomarkerslines'
Browse oncology articles matching biomarkerslines — expert analysis, clinical perspectives, and industry updates from across drug development and care delivery. Use the tabs above for podcasts, press releases, partners, and people for the same search.
Neil Carleton and Priscilla F. McAuliffe
Are the chronological age cutoffs used in clinical oncology guidelines biologically meaningful?
Age, cutoffs, clinical oncology guide, biomarkerslines
Age is a significant risk factor for cancer, influencing tumour biology, treatment recommendations, and therapy response. Breast cancer incidence peaks around 70 years of age, with over one-third of diagnoses in this age group. Clinical guidelines vary in defining "older" patients, using …
Dec 1st • 4 mins read